Does XARELTO Cause Dyspnoea? 97 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Dyspnoea have been filed in association with XARELTO. This represents 2.8% of all adverse event reports for XARELTO.
97
Reports of Dyspnoea with XARELTO
2.8%
of all XARELTO reports
11
Deaths
55
Hospitalizations
How Dangerous Is Dyspnoea From XARELTO?
Of the 97 reports, 11 (11.3%) resulted in death, 55 (56.7%) required hospitalization, and 11 (11.3%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for XARELTO. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does XARELTO Cause?
Pulmonary embolism (276)
Deep vein thrombosis (234)
Drug ineffective (199)
Gastrointestinal haemorrhage (198)
Cerebrovascular accident (180)
Haemoglobin decreased (166)
Fall (124)
Anaemia (123)
Haemorrhage (121)
Cerebral haemorrhage (110)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)